| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225335.2 |
Axitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.045497485 |
Resistant |
| ENSG00000225335.2 |
Axitinib |
Chronic Lymphocytic Leukemia |
0.018417271 |
Resistant |
| ENSG00000225335.2 |
Axitinib |
Lung squamous cell carcinoma |
0.001143905 |
Resistant |
